N-Methyl-D-Aspartate (NMDA)-Type Glutamate Receptors and Demyelinating Disorders: A Neuroimmune Perspective

(2022) N-Methyl-D-Aspartate (NMDA)-Type Glutamate Receptors and Demyelinating Disorders: A Neuroimmune Perspective. Mini Rev Med Chem. ISSN 1389-5575

Full text not available from this repository.

Abstract

N-methyl-D-aspartate receptors (NMDARs) are ionotropic glutamate receptors, highly important in regulating substantial physiologic processes in the brain and the nervous system, and disturbance in their function could contribute to different pathologies. Overstimulation and hyperactivity of NMDARs, termed as glutamate toxicity, could promote cell death and apoptosis. Meanwhile, their blockade could lead to dysfunction of the brain and nervous system as well. A growing body of evidence has demonstrated the prominent role of NMDARs in demyelinating disorders and anti-NMDAR encephalitis. Herein, we provide an overview of the role of NMDARs' dysfunction in the physiopathology of demyelinating disorders such as multiple sclerosis and neuromyelitis optica spectrum disorders.

Item Type: Article
Keywords: N-methyl-D-aspartate receptors Nmdar brain demyelinating disorders neuroimmunology
Journal or Publication Title: Mini Rev Med Chem
Journal Index: Pubmed
Identification Number: https://doi.org/10.2174/1389557522666220504135853
ISSN: 1389-5575
Depositing User: Zahra Otroj
URI: http://eprints.mui.ac.ir/id/eprint/16532

Actions (login required)

View Item View Item